Clinical Trial Information Request for Protocol 2023P001063 Title A Multicenter Phase 2, Double-Blind, Placebo Controlled, Randomized, Parallel-Group Study To Evaluate The Efficacy, Safety, Tolerability, And Pharmacokinetics Of Ucb0022 In Study Participants With Advanced Parkinson’S Disease PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone